Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 521

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 3
Chunk 521
---
,500  
     - 
  
    Stock-based compensation 
     59,803  
     32,831 
  
    Changes in operating assets and liabilities: 

    Accounts receivable 
     379,807  
     (59,547)
  
    Accounts receivable, related party 
     50,614  
     (50,614)
  
    Other current assets 
     491,883  
     203,110 
  
    Right-of-use asset 
        
     121,089 
  
    Accounts payable 
     (361,301) 
     30,603 
  
    Accounts payable, related parties 
     -  
     (3,200)
  
    Deferred revenue 
     16,611  
     - 
  
    Accrued expenses 
     55,672  
     (22,679)
  
    Operating lease liability 
     (89,500) 
     (121,089)
  
    Net cash used in operating activities 
     (2,932,033) 
     (2,759,068)

    CASH FLOWS FROM INVESTING ACTIVITIES 

    Purchase of property and equipment 
     (11,111) 
     (15,251)
  
    Net cash used in investing activities 
     (11,111) 
     (15,251)

    CASH FLOWS FROM FINANCING ACTIVITIES 

    Proceeds from sale of common stock and exercise of warrants 
     2,469,150  
     5,332,283 
  
    Proceeds received from line of credit 
     -  
     300,000 
  
    Repayments on line of credit 
     -  
     (1,050,551)
  
    Proceeds received from advances, related party 
     -  
     1,295,010 
  
    Repayments on advances, related party 
     -  
     (1,095,000)
  
    Repayments on notes payable 
     (410,676) 
     (185,692)
  
    Proceeds received from convertible notes payable 
     -  
     1,455,000 
  
    Net cash provided by financing activities 
     2,058,474  
     6,051,050